Stock 002566 JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Equities

002566

CNE1000011C3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 07/05/2024 am IST 		5-day change 1st Jan Change
7.39 CNY +0.54% Intraday chart for Jilin Jian Yisheng Pharmaceutical Co., Ltd. +4.53% -17.06%
25/04 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
18/04 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. is principally engaged in the research, development, production and distribution of Chinese patent drugs for the treatment of cardiovascular and cerebrovascular disease. The Company’s main products consist of Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The Company's products are applied in the treatment for heart cerebrovascular diseases and detoxification. The company also provides health care products and cosmetics. The Company distributes its products within China market.

Number of employees: 1,678

Sales per Business

CNY in Million2022Weight2023Weight Delta
Capsule
44.5 %
384 46.2 % 380 44.5 % -0.99%
Injection
31.7 %
265 31.9 % 270 31.7 % +2.03%
Others
8.5 %
56 6.7 % 73 8.5 % +29.97%
Ginseng
7.8 %
52 6.3 % 66 7.8 % +26.97%
Cosmetics
7.3 %
72 8.7 % 62 7.3 % -13.76%
Bee Products
0.3 %
1 0.2 % 2 0.3 % +77.77%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
830 100.0 % 854 100.0 % +2.85%

Managers

Managers TitleAgeSince
Xiao Min Xie CEO
 Chief Executive Officer 66 01/09/01
Jian Tao Bi DFI
 Director of Finance/CFO 54 01/11/01
Tie Jun Li PSD
 President 64 01/09/01
Xiao Le Tong CTO
 Chief Tech/Sci/R&D Officer 42 -
Jun Yan Ye BRD
 Director/Board Member 46 11/17/11
Jing Li IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Li Rong Sun BRD
 Director/Board Member 68 11/22/11
Ming Li BRD
 Director/Board Member 62 08/19/08
Yi Sheng Zhang CHM
 Chairman 68 01/00/01
Xiao Min Xie CEO
 Chief Executive Officer 66 01/09/01
Jian Tao Bi DFI
 Director of Finance/CFO 54 01/11/01
Xiao JIng Yu CHM
 Chairman 44 27/19/27
Qi Bin Chen BRD
 Director/Board Member 70 12/23/12
Xiao Le Tong CTO
 Chief Tech/Sci/R&D Officer 42 -
Jun Yan Ye BRD
 Director/Board Member 46 11/17/11
Li Gong Zhang BRD
 Director/Board Member 34 27/22/27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 330,951,600 168,525,369 ( 50.92 %) 0 50.92 %

Shareholders

NameEquities%Valuation
Broad Fund Management Co. Ltd.
1.165 %
2,384,300 1.165 % 2 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.5849 %
1,197,100 0.5849 % 1 M ¥
Gfund Management Co., Ltd.
0.5315 %
1,087,800 0.5315 % 1 M ¥
SWS MU Fund Management Co., Ltd.
0.1440 %
294,800 0.1440 % 294 090 ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.0876 %
179,200 0.0876 % 178 768 ¥
Sealand Securities Co., Ltd. (Investment Management)
0.0422 %
86,300 0.0422 % 86 092 ¥
Bank of Beijing Scotiabank Asset Management Co., Ltd.
0.0324 %
66,400 0.0324 % 66 240 ¥
Bosera Asset Management Co., Ltd.
0.0275 %
56,200 0.0275 % 56 065 ¥
Truvalue Asset Management Co. Ltd.
0.0194 %
39,700 0.0194 % 39 604 ¥
China Asset Management Co., Ltd.
0.003665 %
7,500 0.003665 % 7 482 ¥

Company contact information

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

17-20 Wenhua East Road

134200, Ji'an

+

http://www.yisheng-pharm.com
address Jilin Jian Yisheng Pharmaceutical Co., Ltd.(002566)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. Stock Jilin Jian Yisheng Pharmaceutical Co., Ltd.
-17.06% 339M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.43% 700B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.12% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.59% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.89% 287B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.72% 236B
NOVARTIS AG Stock Novartis AG
+6.67% 202B
ROCHE HOLDING AG Stock Roche Holding AG
-9.37% 197B
AMGEN INC. Stock Amgen Inc.
+4.26% 161B
PFIZER, INC. Stock Pfizer, Inc.
-3.54% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002566 Stock
  4. Company Jilin Jian Yisheng Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW